prikaz prve stranice dokumenta Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma
Access restricted to students and staff of home institution
Scientific paper - Original scientific paper
Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma
Critical Reviews in Oncology/Hematology, 188 (2023); 104062. https://doi.org/10.1016/j.critrevonc.2023.104062
Manestar, Dubravko; Malvić, Goran; Velepič, Marko; Vukelić, Jelena; Vrebac, Ilinko; Tudor, Filip; Vukelić, Ivan; Braut, Tamara

Institutional repository: Repository of the University of Rijeka, Faculty of Medicine

Cite this document

Manestar, D., Malvić, G., Velepič, M., Vukelić, J., Vrebac, I., Tudor, F. ... Braut, T. (2023). Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma. Critical Reviews in Oncology/Hematology, 188.. doi: 10.1016/j.critrevonc.2023.104062

Manestar, Dubravko, et al. "Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma." Critical Reviews in Oncology/Hematology, vol. 188, 2023. https://doi.org/10.1016/j.critrevonc.2023.104062

Manestar, Dubravko, Goran Malvić, Marko Velepič, Jelena Vukelić, Ilinko Vrebac, Filip Tudor, Ivan Vukelić and Tamara Braut. "Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma." Critical Reviews in Oncology/Hematology 188 (2023). https://doi.org/10.1016/j.critrevonc.2023.104062

Manestar, D., et al. (2023) 'Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma', Critical Reviews in Oncology/Hematology, 188. doi: 10.1016/j.critrevonc.2023.104062

Manestar D, Malvić G, Velepič M, Vukelić J, Vrebac I, Tudor F, and sur.. Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma. Critical Reviews in Oncology/Hematology [Internet]. 2023 June 28 [cited 2024 December 25];188. doi: 10.1016/j.critrevonc.2023.104062

D. Manestar, et al., "Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma", Critical Reviews in Oncology/Hematology, vol. 188, June 2023. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:184:093127. [Accessed: 25 December 2024]

Metadata
Title (english)Perioperative substitution testosterone therapy in patients with advanced head and neck squamous cell carcinoma
AuthorDubravko Manestar
AuthorGoran Malvić
AuthorMarko Velepič
AuthorJelena Vukelić
AuthorIlinko Vrebac
AuthorFilip Tudor https://orcid.org/0000-0001-6386-0444
AuthorIvan Vukelić
AuthorTamara Braut
Author's institution(Clinical Hospital Center Rijeka)
Author's institutionUniversity of Rijeka
Faculty of Medicine
(Department of Otorhinolaryngology)
Scientific / art field,
discipline and subdiscipline		BIOMEDICINE AND HEALTHCARE
Clinical Medical Sciences
Otorhinolaryngology
Abstract (english)
Testosterone replacement therapy is becoming more and more popular in men as "anti-aging medicine". Testosterone has beneficial effects on body mass and muscle gain, and much research has examined testosterone in palliative cancer therapy for oncology patients. In addition to direct effects on weight gain, testosterone improves mood and self-confidence, strength, libido, muscle mass, bone density, and cognitive functions and reduces the risk of cardiovascular disease. Lower testosterone levels are found in 65 % of male patients with progressive tumors compared to only 6 % of men in the general population. We hypothesize that perioperative substitution testosterone therapy (PSTT) together with a balanced diet, may be more effective than balanced diet alone in the overall treatment outcome of patients with head and neck squamous cell carcinomas. Therefore, PSTT in combination with a balanced diet should be considered as an additional tool for head and neck carcinoma treatment.
Keywords (english)
Languageenglish
Publication typeScientific paper - Original scientific paper
Publication statusPublished
Peer reviewPeer review - international
Publication versionPublished version
Journal titleCritical Reviews in Oncology/Hematology
Numberingvol. 188, 104062
p-ISSN1040-8428
DOIhttps://doi.org/10.1016/j.critrevonc.2023.104062
URN:NBNurn:nbn:hr:184:093127
Online first2023-06-28
Document URLhttps://linkinghub.elsevier.com/retrieve/pii/S1040842823001506
Type of resourceText
Access conditionsInstitutional access
Terms of useLicence In copyright icon
Created on2023-08-31 08:25:42